Prestige Consumer Healthcare Inc (NYSE:PBH) Shares Bought by Citigroup Inc.

Citigroup Inc. raised its holdings in Prestige Consumer Healthcare Inc (NYSE:PBH) by 72.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 9,271 shares of the company’s stock after purchasing an additional 3,887 shares during the period. Citigroup Inc.’s holdings in Prestige Consumer Healthcare were worth $286,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. State of Tennessee Treasury Department purchased a new position in Prestige Consumer Healthcare during the fourth quarter valued at approximately $4,411,000. Eagle Asset Management Inc. grew its position in Prestige Consumer Healthcare by 3.2% during the fourth quarter. Eagle Asset Management Inc. now owns 216,754 shares of the company’s stock valued at $6,693,000 after purchasing an additional 6,768 shares in the last quarter. Texas Permanent School Fund grew its position in Prestige Consumer Healthcare by 4.0% during the fourth quarter. Texas Permanent School Fund now owns 33,857 shares of the company’s stock valued at $1,046,000 after purchasing an additional 1,306 shares in the last quarter. Bank of New York Mellon Corp grew its position in Prestige Consumer Healthcare by 5.2% during the fourth quarter. Bank of New York Mellon Corp now owns 706,919 shares of the company’s stock valued at $21,830,000 after purchasing an additional 35,048 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA grew its position in Prestige Consumer Healthcare by 21.6% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 355,823 shares of the company’s stock valued at $10,988,000 after purchasing an additional 63,128 shares in the last quarter.

Shares of NYSE PBH traded up $0.43 during trading hours on Friday, hitting $28.08. 338,138 shares of the stock were exchanged, compared to its average volume of 601,188. The company has a market cap of $1.45 billion, a P/E ratio of 10.88, a P/E/G ratio of 1.58 and a beta of 0.98. Prestige Consumer Healthcare Inc has a one year low of $26.25 and a one year high of $41.76. The company has a current ratio of 2.28, a quick ratio of 1.34 and a debt-to-equity ratio of 1.49.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings data on Thursday, February 7th. The company reported $0.73 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.71 by $0.02. Prestige Consumer Healthcare had a net margin of 6.44% and a return on equity of 11.85%. The company had revenue of $241.40 million during the quarter, compared to analysts’ expectations of $241.40 million. During the same quarter in the prior year, the company posted $0.70 EPS. The business’s revenue was down 10.8% on a year-over-year basis. Equities research analysts forecast that Prestige Consumer Healthcare Inc will post 2.77 EPS for the current fiscal year.

Several analysts have commented on PBH shares. Royal Bank of Canada reissued a “buy” rating and issued a $97.00 target price on shares of Prestige Consumer Healthcare in a research report on Friday, March 15th. Raymond James downgraded shares of Prestige Consumer Healthcare from an “outperform” rating to a “market perform” rating and set a $28.40 target price for the company. in a research report on Tuesday, January 15th. Zacks Investment Research downgraded shares of Prestige Consumer Healthcare from a “hold” rating to a “sell” rating in a research report on Wednesday, January 16th. Desjardins downgraded shares of Prestige Consumer Healthcare to a “hold” rating and set a $88.00 target price for the company. in a research report on Wednesday, February 13th. Finally, ValuEngine downgraded shares of Prestige Consumer Healthcare from a “sell” rating to a “strong sell” rating in a report on Thursday, January 10th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $54.07.

TRADEMARK VIOLATION WARNING: “Prestige Consumer Healthcare Inc (NYSE:PBH) Shares Bought by Citigroup Inc.” was originally posted by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/citigroup-inc-increases-position-in-prestige-consumer-healthcare-inc-pbh.html.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Story: Cash Flow

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.